Evidence map›Paper›PMID 33837122›Full record

ArticleJournal of the American Society of Nephrology : JASN2021

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force.

Cynthia Delgado, Mukta Baweja, Nilka Ríos Burrows, Deidra C Crews, Nwamaka D Eneanya, Crystal A Gadegbeku, Lesley A Inker, Mallika L Mendu, W Greg Miller, Marva M Moxey-Mims and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Editorial: Pharmacology Education Special Issue.Pharmacology research & perspectives · 2026
    Article
  3. Article
  4. Article
  5. In defense of empathic informatics.Journal of the American Medical Informatics Association : JAMIA · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Care of Adults with Advanced Chronic Kidney Disease.Journal of clinical medicine · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Diabetic Kidney Disease Prevention Care Model Development.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 14 institutions in 1 country.

Cynthia DelgadoNephrology Section, San Francisco Veterans Affairs Medical Center, Division of Nephrology, University of California San Francisco, San Francisco, California.
Mukta BawejaNephrology Division, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York.
Nilka Ríos BurrowsDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia.
Deidra C CrewsDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0003-3425-5776
Nwamaka D EneanyaRenal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0002-0508-3410
Crystal A GadegbekuDepartment of Medicine, Section of Nephrology, Hypertension and Kidney Transplantation, Temple University, Philadelphia, Pennsylvania.
Lesley A InkerDivision of Nephrology, Tufts Medical Center, Boston, Massachusetts.
Mallika L MenduDivision of Renal Medicine and Office of the Chief Medical Officer, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
W Greg MillerDepartment of Pathology, Virginia Commonwealth University, Richmond, Virginia.
Marva M Moxey-MimsDivision of Nephrology, Children's National Hospital, Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC.
Glenda V RobertsExternal Relations and Patient Engagement, Kidney Research Institute, Center for Dialysis Innovation, University of Washington, Seattle, Washington.
Wendy L St PeterCollege of Pharmacy, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-2201-3019
Curtis WarfieldNational Kidney Foundation, New York, New York.
Neil R PoweDepartment of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California.
Brigham and Women's Hospital · USCenters for Disease Control and Prevention · USGeorge Washington University · USIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USNational Kidney Foundation · USSan Francisco General Hospital · USSan Francisco VA Medical Center · USTemple University · USTufts Medical Center · USUniversity of Minnesota · USUniversity of Pennsylvania · USUniversity of Washington · USVirginia Commonwealth University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For almost two decades, equations that use serum creatinine, age, sex, and race to eGFR have included "race" as Black or non-Black. Given considerable evidence of disparities in health and healthcare delivery in African American communities, some regard keeping a race term in GFR equations as a practice that differentially influences access to care and kidney transplantation. Others assert that race captures important non GFR determinants of serum creatinine and its removal from the calculation may perpetuate other disparities. The National Kidney Foundation (NKF) and American Society of Nephrology (ASN) established a task force in 2020 to reassess the inclusion of race in the estimation of GFR in the United States and its implications for diagnosis and subsequent management of patients with, or at risk for, kidney diseases. This interim report details the process, initial assessment of evidence, and values defined regarding the use of race to estimate GFR. We organized activities in phases: (

Indexed as

Advisory CommitteesGlomerular Filtration RateRace FactorsVoluntary Health AgenciesHealthcare DisparitiesHealth Status DisparitiesHumansKidney DiseasesMathematical ConceptsUnited Statesestimated glomerular filtration ratehealth disparitieshealth equitykidney functionrace

Identifiers

PMID33837122
PMCPMC8259639
OpenAlexW3149639442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.